JP Morgan maintains Axon Enterprise at Overweight, lowers price target to $610 from $755

What happened

JP Morgan kept its Overweight rating on Axon Enterprise but cut its price target to $610 from $755, a 19.2% decrease. The revised target implies 94.9% upside from the November 6 closing price of $313.

Confirmed

Global impact / market context

The lower target signals JP Morgan sees less potential value than before, although its Overweight rating remains favorable. If investors respond by changing their holdings, Axon’s share price and the company’s ability to raise funds through stock sales could be affected; the article reports no such reaction.

Analyst inference

Recent analyst targets vary widely: four notes from the past 30 days range from $500 to $800. JP Morgan’s $610 target sits within that range, while its implied upside is based on the November 6 close, not a reported current price.

Confirmed

What to watch

1. Check whether JP Morgan gives reasons for the cut in a fuller report; the supplied article states the new target and rating but does not explain the change. Analyst inference
2. Compare future analyst targets with the reported $500–$800 range; further cuts or increases could change investor expectations, though no later revisions are reported here. Analyst inference
3. Watch for Axon’s reported financial results or company updates that could support or challenge analyst expectations; the supplied article provides no operating or financial explanation for the target change. Analyst inference

Evidence

• Original source link unavailable